‹ Knowledge base
Browse the corpus
Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.
- Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review1 passage
- Does technology-enhanced communication improve Helicobacter pylori eradication outcomes?-A meta-analysis1 passage
- Efficacy and Safety of Vonoprazan-Based Dual Therapies With Different Antibiotics Versus Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Prospective, Four-Arm, Randomized Controlled Trial1 passage
- Efficacy and Safety of Vonoprazan-Based Dual, Triple, and Quadruple Therapies for Helicobacter pylori Eradication: A Randomized Controlled Trial1 passage
- Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for Helicobacter pylori Eradication: A Randomized Noninferiority Trial1 passage
- Helicobacter pylori Eradication in Older Individuals: A Systematic Review and Meta-Analysis1 passage
- High-Dose Dual Therapy Versus Bismuth-Containing Quadruple Therapy as Rescue Treatment for Helicobacter pylori Infection: Systematic Review and Meta-Analysis1 passage
- Impact of smoking on the eradication of Helicobacter pylori1 passage
- PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis1 passage
- Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial1 passage
- Tegoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China1 passage
- Tegoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial1 passage
- Vonoprazan Versus Tegoprazan-Amoxicillin Dual Therapy for Treatment-Naïve Patients With Helicobacter pylori Infection: A Prospective, Multicenter, Open-Label, Randomized Controlled Study1 passage